PrimeVax Immuno-Oncology

PrimeVax Immuno-Oncology is a company that develops a multi-mechanism treatment for cancer, leveraging whole body systemic fever along with personalized neo-antigens. It combines dengue fever virus and autologous dendritic cells to induce a strong immune response along with personalized tumor targeting.